vs
Monte Rosa Therapeutics, Inc.（GLUE）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
Monte Rosa Therapeutics, Inc.的季度营收约是NexPoint Real Estate Finance, Inc.的1.2倍（$12.8M vs $11.1M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -212.1%，领先428.7%），Monte Rosa Therapeutics, Inc.同比增速更快（38.5% vs -48.8%）
Monte Rosa Therapeutics是一家临床阶段生物技术企业，专注于研发靶向分子胶降解剂疗法，管线覆盖肿瘤、罕见遗传病及免疫疾病领域的未满足医疗需求，通过自主研发与行业合作推进创新疗法惠及全球患者。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
GLUE vs NREF — 直观对比
营收规模更大
GLUE
是对方的1.2倍
$11.1M
营收增速更快
GLUE
高出87.4%
-48.8%
净利率更高
NREF
高出428.7%
-212.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.8M | $11.1M |
| 净利润 | $-27.1M | $24.0M |
| 毛利率 | — | — |
| 营业利润率 | -258.3% | — |
| 净利率 | -212.1% | 216.6% |
| 营收同比 | 38.5% | -48.8% |
| 净利润同比 | -13.5% | 58.7% |
| 每股收益（稀释后） | — | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLUENREF
| Q4 25 | — | $11.1M | ||
| Q3 25 | $12.8M | $12.5M | ||
| Q2 25 | $23.2M | $12.1M | ||
| Q1 25 | $84.9M | $11.5M | ||
| Q4 24 | $60.6M | $21.7M | ||
| Q3 24 | — | $12.5M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | — | $-12.8M |
净利润GLUENREF
| Q4 25 | — | $24.0M | ||
| Q3 25 | $-27.1M | $50.9M | ||
| Q2 25 | $-12.3M | $22.3M | ||
| Q1 25 | $46.9M | $26.0M | ||
| Q4 24 | $13.4M | $15.2M | ||
| Q3 24 | — | $23.3M | ||
| Q2 24 | — | $12.1M | ||
| Q1 24 | — | $-14.6M |
营业利润率GLUENREF
| Q4 25 | — | — | ||
| Q3 25 | -258.3% | — | ||
| Q2 25 | -67.1% | — | ||
| Q1 25 | 51.9% | — | ||
| Q4 24 | 21.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
净利率GLUENREF
| Q4 25 | — | 216.6% | ||
| Q3 25 | -212.1% | 407.0% | ||
| Q2 25 | -53.0% | 184.5% | ||
| Q1 25 | 55.2% | 225.6% | ||
| Q4 24 | 22.2% | 69.9% | ||
| Q3 24 | — | 186.4% | ||
| Q2 24 | — | 179.7% | ||
| Q1 24 | — | 114.3% |
每股收益（稀释后）GLUENREF
| Q4 25 | — | $0.47 | ||
| Q3 25 | — | $1.14 | ||
| Q2 25 | — | $0.54 | ||
| Q1 25 | — | $0.70 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | — | $0.40 | ||
| Q1 24 | — | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.3M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | $245.8M | $388.0M |
| 总资产 | $459.8M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资GLUENREF
| Q4 25 | — | $31.1M | ||
| Q3 25 | $208.3M | $17.9M | ||
| Q2 25 | $69.4M | $9.1M | ||
| Q1 25 | $78.5M | $19.2M | ||
| Q4 24 | $224.3M | $3.9M | ||
| Q3 24 | — | $34.7M | ||
| Q2 24 | — | $4.3M | ||
| Q1 24 | — | $13.5M |
总债务GLUENREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益GLUENREF
| Q4 25 | — | $388.0M | ||
| Q3 25 | $245.8M | $375.4M | ||
| Q2 25 | $268.1M | $348.2M | ||
| Q1 25 | $275.2M | $343.7M | ||
| Q4 24 | $222.9M | $336.5M | ||
| Q3 24 | — | $335.8M | ||
| Q2 24 | — | $327.5M | ||
| Q1 24 | — | $327.1M |
总资产GLUENREF
| Q4 25 | — | $5.3B | ||
| Q3 25 | $459.8M | $5.3B | ||
| Q2 25 | $359.6M | $5.4B | ||
| Q1 25 | $393.2M | $5.4B | ||
| Q4 24 | $438.7M | $5.4B | ||
| Q3 24 | — | $5.7B | ||
| Q2 24 | — | $6.6B | ||
| Q1 24 | — | $7.1B |
负债/权益比GLUENREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.4M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | $99.8M | — |
| 自由现金流率自由现金流/营收 | 781.5% | — |
| 资本支出强度资本支出/营收 | 5.1% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | $145.0M | — |
8季度趋势，按日历期对齐
经营现金流GLUENREF
| Q4 25 | — | $-4.5M | ||
| Q3 25 | $100.4M | $8.1M | ||
| Q2 25 | $-34.7M | $3.3M | ||
| Q1 25 | $-45.5M | $16.0M | ||
| Q4 24 | $128.9M | $4.4M | ||
| Q3 24 | — | $14.7M | ||
| Q2 24 | — | $-7.5M | ||
| Q1 24 | — | $17.7M |
自由现金流GLUENREF
| Q4 25 | — | — | ||
| Q3 25 | $99.8M | — | ||
| Q2 25 | $-36.4M | — | ||
| Q1 25 | $-47.1M | — | ||
| Q4 24 | $128.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率GLUENREF
| Q4 25 | — | — | ||
| Q3 25 | 781.5% | — | ||
| Q2 25 | -157.0% | — | ||
| Q1 25 | -55.4% | — | ||
| Q4 24 | 212.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度GLUENREF
| Q4 25 | — | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率GLUENREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | -0.97× | 0.62× | ||
| Q4 24 | 9.59× | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
